Recurrence of Obstructive Symptoms and Quality of Life After Insertion of Non-Cover Metal Stent Inside the Biliary Duct in Patients with Pancreatic Cancer

Overview

Journal Maedica (Bucur)

Specialty General Medicine

Date 2020 May 19

PMID 32419863

Citations 1

Authors

Hassan Salmanroghani

Samira Akbarian

Roham Salman Roghani

Affiliations

Soon will be listed here.

Abstract

Quality of disease is improved in patients with pancreatic cancer via endoscopic placement of a biliary stent. Since the role of non-cover metal stent inside the biliary duct is not definitely clear, the aim of this study was to evaluate the recurrence of obstructive symptoms and quality of life after insertion of non-cover metal stent inside the biliary duct in patients with pancreatic cancer. This retrospective descriptive-analytical study was conducted on 81 patients with pancreatic cancer who were referred to Mortaz and Shahaid Sadoughi Hospital. Factors such as pruritus, jaundice, appetite, stomachache and general situation were measured. Quality of life assessment was performed using the Functional Assessment of Cancer Therapy-Hepatobiliary questionnaire (version 4). Then, the quality of life score was classified in terms of median score (more and less than 18). Patients had a mean age of 72±12.15 years. The most complete recovery among them was related to jaundice (54.3%) and pruritus (47.4%). Subjects had a mean quality of life score of 21.60±6.24. Moreover, the mean quality of life score of 37.2% and 62.8% of patients was less and more than the median value, respectively. In addition, there was no significant difference between frequency of recurrence in terms of variables including sex, age, death, chemotherapy, surgery, and quality of life (p>0.05). The mean recurrence time was 6.9±5.03 months. According to our findings, the quality of life score of most patients using metal stent is higher than 18. Therefore, it seems that the use of metal stent can improve the quality of life score in these patients. Stenting also improves jaundice and pruritus in these subjects. In addition, because there is no significant relation between the frequency of recurrence with age, mortality, chemotherapy, and quality of life, it can be concluded that none of the above factors affects the frequency of recurrence among patients with pancreatic cancer.

Citing Articles

Surgical Palliation for Advanced Pancreas Cancer.

Jacobs C, Vitello D, Chawla A Surg Clin North Am. 2024; 104(5):1121-1135.

PMID: 39237168 PMC: 11377866. DOI: 10.1016/j.suc.2024.04.008.

References

Decker C, Christein J, Phadnis M, Wilcox C, Varadarajulu S . Biliary metal stents are superior to plastic stents for preoperative biliary decompression in pancreatic cancer. Surg Endosc. 2011; 25(7):2364-7. PMC: 3116134. DOI: 10.1007/s00464-010-1552-6. View

Boulay B . Biliary stents for pancreas cancer with obstruction: the problem with plastic. J Gastrointest Oncol. 2012; 3(4):306-8. PMC: 3492473. DOI: 10.3978/j.issn.2078-6891.2012.047. View

Dy S, Harman S, Braun U, Howie L, Harris P, Jayes R . To stent or not to stent: an evidence-based approach to palliative procedures at the end of life. J Pain Symptom Manage. 2012; 43(4):795-801. PMC: 4696003. DOI: 10.1016/j.jpainsymman.2011.12.269. View

Kaassis M, Boyer J, Dumas R, Ponchon T, Coumaros D, Delcenserie R . Plastic or metal stents for malignant stricture of the common bile duct? Results of a randomized prospective study. Gastrointest Endosc. 2003; 57(2):178-82. DOI: 10.1067/mge.2003.66. View

Walter D, van Boeckel P, Groenen M, Weusten B, Witteman B, Tan G . Higher quality of life after metal stent placement compared with plastic stent placement for malignant extrahepatic bile duct obstruction: a randomized controlled trial. Eur J Gastroenterol Hepatol. 2016; 29(2):231-237. DOI: 10.1097/MEG.0000000000000762. View

Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T . Cancer statistics, 2008. CA Cancer J Clin. 2008; 58(2):71-96. DOI: 10.3322/CA.2007.0010. View

Aadam A, Evans D, Khan A, Oh Y, Dua K . Efficacy and safety of self-expandable metal stents for biliary decompression in patients receiving neoadjuvant therapy for pancreatic cancer: a prospective study. Gastrointest Endosc. 2012; 76(1):67-75. DOI: 10.1016/j.gie.2012.02.041. View

Singh P, Singh A, Singh A, Sharma G, Bhatia P, Grover A . Long Term Outcome in Patients with Esophageal Stenting for Cancer Esophagus - Our Experience at a Rural Hospital of Punjab, India. J Clin Diagn Res. 2017; 10(12):PC06-PC09. PMC: 5296496. DOI: 10.7860/JCDR/2016/22950.8994. View

Adams M, Anderson M, Myles J, Khalatbari S, Scheiman J . Self-expanding metal stents (SEMS) provide superior outcomes compared to plastic stents for pancreatic cancer patients undergoing neoadjuvant therapy. J Gastrointest Oncol. 2012; 3(4):309-13. PMC: 3492479. DOI: 10.3978/j.issn.2078-6891.2011.050. View

10.

Yoon S, Lee I, Choi M . Metal versus plastic stents for drainage of pancreatic fluid collection: A meta-analysis. United European Gastroenterol J. 2018; 6(5):729-738. PMC: 6068780. DOI: 10.1177/2050640618761702. View

11.

Yeoh K, Zimmerman M, Cunningham J, Cotton P . Comparative costs of metal versus plastic biliary stent strategies for malignant obstructive jaundice by decision analysis. Gastrointest Endosc. 1999; 49(4 Pt 1):466-71. DOI: 10.1016/s0016-5107(99)70044-1. View

12.

Sakai A, Shiomi H, Okabe Y, Yagi Y, Kobayashi T, Shiomi Y . Effectiveness of endoscopic self-expandable metal stent placement for afferent loop obstruction caused by pancreatic cancer recurrence after pancreaticoduodenectomy. Clin J Gastroenterol. 2015; 8(2):103-7. DOI: 10.1007/s12328-015-0556-0. View

13.

Barkay O, Mosler P, Schmitt C, Lehman G, Frakes J, Johanson J . Effect of endoscopic stenting of malignant bile duct obstruction on quality of life. J Clin Gastroenterol. 2012; 47(6):526-31. DOI: 10.1097/MCG.0b013e318272440e. View

14.

Lee H, Park J, Shin S, Lee S, Lee Y . Preliminary study of enteroscopy-guided, self-expandable metal stent placement for malignant small bowel obstruction. J Gastroenterol Hepatol. 2012; 27(7):1181-6. DOI: 10.1111/j.1440-1746.2012.07113.x. View

15.

Hong H, Kim S, Seo T . Percutaneous metallic stents in patients with obstructive jaundice due to hepatocellular carcinoma. J Vasc Interv Radiol. 2008; 19(5):748-54. DOI: 10.1016/j.jvir.2007.12.455. View

16.

Ballinger A, McHugh M, Catnach S, Alstead E, Clark M . Symptom relief and quality of life after stenting for malignant bile duct obstruction. Gut. 1994; 35(4):467-70. PMC: 1374793. DOI: 10.1136/gut.35.4.467. View

17.

Woradet S, Songserm N, Promthet S, Parkin D . Health-Related Quality of Life and Survival of Cholangiocarcinoma Patients in Northeastern Region of Thailand. PLoS One. 2016; 11(9):e0163448. PMC: 5042427. DOI: 10.1371/journal.pone.0163448. View